Jasbir Seehra

Insider Reports History

Entity
Individual
Location
C/O Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jasbir Seehra:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 253K $11.5M $45.29 Apr 8, 2023 Direct
Keros Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Employee Stock Option (right to buy) 125K Feb 23, 2024 Direct
Eloxx Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 20K Jun 15, 2022 Direct

Insider Reports Filed by Jasbir Seehra

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. Feb 23, 2024 1 $0 4 Feb 23, 2024 CHIEF EXECUTIVE OFFICER, Director
KROS Keros Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 CHIEF EXECUTIVE OFFICER, Director
KROS Keros Therapeutics, Inc. Apr 8, 2023 2 $1.92K 4 Apr 11, 2023 Chief Executive Officer, Director
KROS Keros Therapeutics, Inc. Feb 16, 2023 1 $0 4 Feb 17, 2023 Chief Executive Officer, Director
ELOX Eloxx Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
KROS Keros Therapeutics, Inc. Jun 9, 2022 2 $1.5K 4 Jun 10, 2022 Chief Executive Officer, Director
KROS Keros Therapeutics, Inc. Jan 21, 2022 1 $0 4 Jan 25, 2022 Chief Executive Officer, Director
ELOX Eloxx Pharmaceuticals, Inc. May 19, 2021 1 $0 4 May 20, 2021 Director